Effects of oral semaglutide on heart failure outcomes in people with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease participating in SOUL trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.